Ambit Biosciences Corporation (AMBI) was a big mover last session, as the company saw its shares rise just over 10% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend for the company, as the stock is now trading above the past one month’s volatile price range of $5.94 to $6.96.
This biopharmaceutical company has seen no estimate revision in the last 7 days. The Zacks Consensus Estimate has also remained unchanged over the same time frame. Friday’s rally is encouraging though, so make sure to keep a close watch on this firm in the near future.
Ambit Biosciences currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.
Some better-ranked Biomedical stocks worth considering are Gilead Sciences Inc. (GILD), Myriad Genetics Inc. (MYGN) and Illumina Inc. (ILMN). All three stocks hold a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
AMBIT BIOSCIENCES CORP (AMBI): Free Stock Analysis Report
GILEAD SCIENCES INC (GILD): Free Stock Analysis Report
MYRIAD GENETICS INC (MYGN): Free Stock Analysis Report
ILLUMINA INC (ILMN): Free Stock Analysis Report
Zacks Investment Research